Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Kane Biotech Inc
V.KNE
Alternate Symbol(s):
KNBIF
Healthcare
Biotechnology
Kane Biotech Inc. is a Canada-based biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (66 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired...
from research institutions. DispersinB, coactiv+, coactiv+, DermaKB, DermaKB Biofilm, and revive are trademarks of the Company. Its patented coactiv+ technology is specifically formulated to destabilize biofilm and create an environment for fast wound healing. In Wound Care & Surgical applications, in addition to revyve Antimicrobial Wound Gel, it is developing follow-on products with three applications: coactiv+ Antimicrobial Surgical Hydrogel, coactiv+ Antimicrobial Wound Gel Spray, and coactiv+ Antimicrobial Wound Rinse. The Company's other biofilm disruption technology is DispersinB.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:KNE)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
Next
(208)
•••
StoneMan45
X
View Profile
View Bullboard History
Comment by
StoneMan45
on Feb 18, 2021 10:04am
RE:Kane
selling at 11.5 ...way low .
(208)
•••
StoneMan45
X
View Profile
View Bullboard History
Post by
StoneMan45
on Feb 18, 2021 9:55am
Kane
would be nice to see trading volume up a bit but it will come. June should be a good month.
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 24, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(208)
•••
StoneMan45
X
View Profile
View Bullboard History
Post by
StoneMan45
on Feb 17, 2021 1:29pm
kne
no one want to sell? slow day
(208)
•••
StoneMan45
X
View Profile
View Bullboard History
Post by
StoneMan45
on Feb 17, 2021 10:13am
anytime
been a bit since a news release
(75)
•••
francoisl13
X
View Profile
View Bullboard History
Post by
francoisl13
on Jan 25, 2021 11:39am
Animalcare - January 21st 2021 Press Release
From Animalcare latest press release; ''Commercial developments Kevin Cole has been appointed President and CEO of STEM Animal Health Inc., the subsidiary created from the recently formed
...more
(208)
•••
StoneMan45
X
View Profile
View Bullboard History
Comment by
StoneMan45
on Jan 06, 2021 12:08pm
RE:some of Kanes Dec presentation
okay...looked like it posted but it didn't
(208)
•••
StoneMan45
X
View Profile
View Bullboard History
Post by
StoneMan45
on Jan 06, 2021 12:07pm
some of Kanes Dec presentation
2736-KAN-Investor+Presentation+Dec+2020+.pdf (d1io3yog0oux5.cloudfront.net)
(208)
•••
StoneMan45
X
View Profile
View Bullboard History
Comment by
StoneMan45
on Jan 05, 2021 1:46pm
RE:Starting the new year
took a slight gain but did the tfsa transfer-in-kind 44,444 shares in :)
(208)
•••
StoneMan45
X
View Profile
View Bullboard History
Post by
StoneMan45
on Jan 03, 2021 1:54pm
Starting the new year
hopefully Monday will be a good time for a transfer-in-kind of over 40,000 KNE shares to my tfsa..between that or VIV.
(208)
•••
StoneMan45
X
View Profile
View Bullboard History
Comment by
StoneMan45
on Dec 31, 2020 9:27am
RE:RE:RE:RE:Kane latest presentation (Dec.16th,2020) - Link
you are correct... either way it's a win but I'm hoping page 8
(2136)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Dec 30, 2020 7:39pm
RE:RE:RE:Kane latest presentation (Dec.16th,2020) - Link
So slides 8 and 14 differ. Which is correct?
(208)
•••
StoneMan45
X
View Profile
View Bullboard History
Comment by
StoneMan45
on Dec 30, 2020 7:06pm
RE:RE:Kane latest presentation (Dec.16th,2020) - Link
actually states ..."DispersinB® Wound Care biofilm wash PMA or BLA 1st Wound Care Bioburden claims Launching in 2022 2024 Sales projections
...more
(72)
•••
MirrorWorldMan
X
View Profile
View Bullboard History
Comment by
MirrorWorldMan
on Dec 21, 2020 10:46pm
RE:RE:Kane latest presentation (Dec.16th,2020) - Link
Its nice to be invested in a solid well resourced Canadian BioTech company with solid transparent partner deals in place and products that are commercialized, with rigid business plans and financing
...more
(2136)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Dec 18, 2020 11:44am
RE:Kane latest presentation (Dec.16th,2020) - Link
By Q2 2021 Kane will sign a partnership with US co. where US co. will pay $7 million Cdn to Kane for a 10% ownership in the partnership valuing this part of Kane business at $70 million.
...more
Prev
...
21
22
23
24
25
26
27
28
29
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >